TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
18 hedge funds and large institutions have $1.14M invested in Titan Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
18
Holding in Top 10
–
Calls
$45K
Puts
–
Top Buyers
| 1 | +$675K | |
| 2 | +$41K | |
| 3 | +$30K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.54K |
Top Sellers
| 1 | -$103K | |
| 2 | -$49.7K | |
| 3 | -$37.2K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$33K |
| 5 |
HF
HRT Financial
New York
|
-$29K |